NEW YORK (
) hit a new 52-week high Tuesday as it is currently trading at $69.95, above its previous 52-week high of $69.01 with 31,165 shares traded as of 9:36 a.m. ET. Average volume has been 118,600 shares over the past 30 days.
Chemed has a market cap of $1.4 billion and is part of the
industry. Shares are up 4.5% year to date as of the close of trading on Monday.
Chemed Corporation, through its subsidiaries, provides hospice care, and repair and maintenance services in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice services for patients with severe and life-limiting illnesses. The company has a P/E ratio of 18.6, below the average health services industry P/E ratio of 19 and above the S&P 500 P/E ratio of 16.7.
- Practice your CHE trading strategies and win cash in our stock game.
TheStreet Ratings rates Chemed as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our